149 related articles for article (PubMed ID: 36380699)
1. Perturbations of immune landscape in COVID-19 associated mucormycosis.
Desai N; Pradhan V; Chougule D; Tiwari S; Mandke C; Yadav RM; Athvale A; Kawle J; Pai V; Pawaskar S; Kharkar H; Bhosale S; Parab A; Ansari S; Kumar KH; Mhashal S; Redkar N; Madkaikar M
Mycoses; 2023 Mar; 66(3):226-236. PubMed ID: 36380699
[TBL] [Abstract][Full Text] [Related]
2. Higher proinflammatory responses possibly contributing to suppressed cytotoxicity in patients with COVID-19 associated mucormycosis.
Shete A; Deshpande S; Sawant J; Warthe N; Thakar M; Madkaikar M; Pradhan V; Rao P; Rohatgi S; Mukherjee A; Anand T; Satija A; Sharma Velamuri P; Das M; Deasi N; Kumar Tembhurne A; Yadav R; Pawaskar S; Rajguru C; Sankhe LR; Chavan SS; Panda S
Immunobiology; 2023 May; 228(3):152384. PubMed ID: 37071959
[TBL] [Abstract][Full Text] [Related]
3. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
4. Serum iron indices in COVID-19-associated mucormycosis: A case-control study.
Kumar H M; Sharma P; Rudramurthy SM; Sehgal IS; Prasad KT; Pannu AK; Das R; Panda NK; Sharma N; Chakrabarti A; Agarwal R; Muthu V
Mycoses; 2022 Jan; 65(1):120-127. PubMed ID: 34743358
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.
Huang SF; Ying-Jung Wu A; Shin-Jung Lee S; Huang YS; Lee CY; Yang TL; Wang HW; Chen HJ; Chen YC; Ho TS; Kuo CF; Lin YT;
J Microbiol Immunol Infect; 2023 Jun; 56(3):442-454. PubMed ID: 36586744
[TBL] [Abstract][Full Text] [Related]
6. Mucormycosis, past and present: a comprehensive review.
Gupta I; Baranwal P; Singh G; Gupta V
Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978
[TBL] [Abstract][Full Text] [Related]
7. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
[TBL] [Abstract][Full Text] [Related]
8. Mucormycosis in COVID-19 patients: predisposing factors, prevention and management.
Rudrabhatla PK; Reghukumar A; Thomas SV
Acta Neurol Belg; 2022 Apr; 122(2):273-280. PubMed ID: 34820787
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 associated mucormycosis surge: A review on multi-pathway mechanisms.
Pourazizi M; Hakamifard A; Peyman A; Mohammadi R; Dehghani S; Tavousi N; Hosseini NS; Azhdari Tehrani H; Abtahi-Naeini B
Parasite Immunol; 2024 Jan; 46(1):e13016. PubMed ID: 37846902
[TBL] [Abstract][Full Text] [Related]
10. [COVID-19 associated mucormycosis. A case in Argentina].
Aparicio M; Tuculet B; Rivolier MG; Forte A; Vila A
Medicina (B Aires); 2022; 82(2):304-307. PubMed ID: 35417397
[TBL] [Abstract][Full Text] [Related]
11. Mucormycosis an added burden to Covid-19 Patients: An in-depth systematic review.
Shah NN; Khan Z; Ahad H; Elderdery AY; Alomary MN; Atwah B; Alhindi Z; Alsugoor MH; Elkhalifa AME; Nabi S; Bashir SM; Yaqub T; Rather GA; Ansari MA
J Infect Public Health; 2022 Nov; 15(11):1299-1314. PubMed ID: 36279686
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated mucormycosis, diabetes and steroid therapy: Experience in a single centre in Western Mexico.
Guzmán-Castro S; Chora-Hernandez LD; Trujillo-Alonso G; Calvo-Villalobos I; Sanchez-Rangel A; Ferrer-Alpuin E; Ruiz-Jimenez M; Corzo-Leon DE
Mycoses; 2022 Jan; 65(1):65-70. PubMed ID: 34674319
[TBL] [Abstract][Full Text] [Related]
14. Deficient Phagocytosis in Circulating Monocytes from Patients with COVID-19-Associated Mucormycosis.
Sinha BP; Mehta P; Hoque MA; Bandopadhyay P; Nandi A; Saha I; Nandi Mitra A; Mondal A; Bhattacharjee B; Chamilos G; Pandey R; Basu K; Ganguly D
mBio; 2023 Jun; 14(3):e0059023. PubMed ID: 37052373
[TBL] [Abstract][Full Text] [Related]
15. Quantitative B and T cell abnormalities in four patients presenting with mucormycosis and prior asymptomatic COVID-19 infection.
Mandke C; Divekar R; Pradhan V; Arora S
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35944939
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic.
Bhanuprasad K; Manesh A; Devasagayam E; Varghese L; Cherian LM; Kurien R; Karthik R; Deodhar D; Vanjare H; Peter J; Michael JS; Thomas M; Samuel P; Varghese GM
Int J Infect Dis; 2021 Oct; 111():267-270. PubMed ID: 34450284
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic.
Kulkarni R; Pujari SS; Gupta D; Ojha P; Dhamne M; Bolegave V; Dhonde P; Soni A; Adwani S; Diwan A; Duberkar D; Batra D; Deshpande R; Aurangabadkar K; Palasdeokar N
J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106231. PubMed ID: 34890962
[TBL] [Abstract][Full Text] [Related]
18. A case control investigation of COVID-19 associated mucormycosis in India.
Anand T; Mukherjee A; Satija A; Velamuri PS; Singh KJ; Das M; Josten K; Yadav PD; Sahay RR; Keche AY; Nagarkar NM; Gupta P; Himanshu D; Mistry SN; Patel JD; Rao P; Rohatgi S; Ghosh S; Hazra A; Kindo AJ; Annamalai R; Rudramurthy SM; Singh MP; Shameem M; Fatima N; Khambholja JR; Parikh S; Madkaikar M; Pradhan VD; Kataria S; Sharma P; Panda S;
BMC Infect Dis; 2022 Nov; 22(1):856. PubMed ID: 36384482
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 associated mucormycosis - An emerging threat.
Chao CM; Lai CC; Yu WL
J Microbiol Immunol Infect; 2022 Apr; 55(2):183-190. PubMed ID: 35074291
[TBL] [Abstract][Full Text] [Related]
20. Mucormycosis (black fungus) ensuing COVID-19 and comorbidity meets - Magnifying global pandemic grieve and catastrophe begins.
Pushparaj K; Kuchi Bhotla H; Arumugam VA; Pappusamy M; Easwaran M; Liu WC; Issara U; Rengasamy KRR; Meyyazhagan A; Balasubramanian B
Sci Total Environ; 2022 Jan; 805():150355. PubMed ID: 34818767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
